Clicky

Swedish Orphan Biovitrum AB (publ)(B6E) News

Date Title
Feb 20 EMA validates indication extension application for Aspaveli® for treatment of C3G and primary IC-MPGN
Feb 20 Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN